Author

S. Stapleton

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:gene regulatory network inference· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Burford· 1 shared A. Carai· 1 shared A. Garancher· 1 shared A. Mackay· 1 shared A. Martin· 1 shared A. Mastronuzzi· 1 shared B. Dabbous· 1 shared B. Lee· 1 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Burford

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Unravelling the Impact of miR-21 Overexpression on the MicroRNA Network and Cancer Pathways

M. Hill, S. Stapleton, P. T. Nguyen, D. Sais, F. Deutsch, V. Gay, D. Marsh, N. Tran

This study investigates how miR-21 overexpression affects miRNA networks and cancer-related pathways by identifying miR-17-92a as a potential target and showing shifts in miRNA expression.

bioRxiv · May 10, 2024 · PreprintCell Biology

Drug screening linked to molecular profiling identifies novel dependencies in patient-derived primary cultures of paediatric high grade glioma and DIPG

D. Carvalho, S. Temelso, A. Mackay, H. Pemberton, R. Rogers, K. Kessler, E. Izquierdo, L. Bjerke, J. Fazal-Salom, M. Clarke, Y. Grabovska, A. Burford, N. Gene-Olaciregui, J. Boult, V. Molinari, , Hubank

bioRxiv · Dec 29, 2020 · PreprintCancer Biology

The long non-coding RNA lnc-HLX-2-7 is oncogenic in group 3 medulloblastomas

K. Katsushima, B. Lee, H. Kunhiraman, C. Zhong, R. Murath, J. Ying, B. Liu, A. Garancher, H. L. Monforte, I. Gonzalez-Gomez, S. Stapleton, R. Vibhakar, C. Bettegowda, R. J. Wechsler-Reya, G. Jallo, , R. J. Perera

This study identifies lnc-HLX-2-7 as an oncogenic lncRNA in group 3 medulloblastomas, showing it promotes tumor growth and is regulated by MYC and JQ1.

bioRxiv · Jun 8, 2020Cancer Biology